Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Metadata
Title
Simultaneous assessment of myocardial perfusion and function during mental stress in patients with chronic coronary artery disease
Authors
James A. Arrighi
Matthew Burg
Ira S. Cohen
Robert Soufer
Publication date
01-05-2003
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 3/2003
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1016/S1071-3581(02)43235-7

Other articles of this Issue 3/2003

Journal of Nuclear Cardiology 3/2003 Go to the issue

OriginalPaper

Gated fluorine 18 fluorodeoxyglucose positron emission tomography: Determination of global and regional left ventricular function and myocardial tissue characterization

OriginalPaper

Favorable cardiac remodeling in dilated cardiomyopathy: Potential assessment with serial myocardial perfusion imaging

Erratum

Correction

OriginalPaper

Long-term prognosis after a normal exercise stress Tc-99m sestamibi SPECT study

OriginalPaper

The impact of adjunctive adenosine infusion during exercise myocardial perfusion imaging: Results of the Both Exercise and Adenosine Stress Test (BEAST) trial

Editorial

Is a revision of the “Nuclear cardiology warranty“ in order?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits